These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

366 related articles for article (PubMed ID: 1983397)

  • 1. [Current concepts of the effects of neuroleptics].
    Kostowski W; Płaźnik A
    Psychiatr Pol; 1990; 24(5):28-37. PubMed ID: 1983397
    [No Abstract]   [Full Text] [Related]  

  • 2. Neuropharmacology of second-generation antipsychotic drugs: a validity of the serotonin-dopamine hypothesis.
    Kuroki T; Nagao N; Nakahara T
    Prog Brain Res; 2008; 172():199-212. PubMed ID: 18772034
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alterations of dopamine and serotonin transmission in schizophrenia.
    Remington G
    Prog Brain Res; 2008; 172():117-40. PubMed ID: 18772030
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antipsychotic drug effects on dopamine and serotonin receptors: in vitro binding and in vivo turnover studies.
    Bacopoulos NG
    J Pharmacol Exp Ther; 1981 Dec; 219(3):708-14. PubMed ID: 6170752
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vivo actions of atypical antipsychotic drug on serotonergic and dopaminergic systems.
    Meltzer HY; Huang M
    Prog Brain Res; 2008; 172():177-97. PubMed ID: 18772033
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alterations of serotonin transmission in schizophrenia.
    Abi-Dargham A
    Int Rev Neurobiol; 2007; 78():133-64. PubMed ID: 17349860
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Problem of neuronal reception and the dopamine hypothesis of schizophrenia].
    Lideman RR; Zlobina GP; Mukhin AG
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1980; 80(5):762-9. PubMed ID: 6106337
    [No Abstract]   [Full Text] [Related]  

  • 8. Does loxapine have "atypical" properties? Clinical evidence.
    Glazer WM
    J Clin Psychiatry; 1999; 60 Suppl 10():42-6. PubMed ID: 10340686
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neurochemical alterations in schizophrenia affecting the putative receptor targets of atypical antipsychotics. Focus on dopamine (D1, D3, D4) and 5-HT2a receptors.
    Harrison PJ
    Br J Psychiatry Suppl; 1999; (38):12-22. PubMed ID: 10884896
    [No Abstract]   [Full Text] [Related]  

  • 10. [Flupenthixol--a partial atypical neuroleptic?].
    Kühn KU; Meyer K; Maier W
    Fortschr Neurol Psychiatr; 2000 Apr; 68 Suppl 1():S38-41. PubMed ID: 10907612
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serotonin receptors: their key role in drugs to treat schizophrenia.
    Meltzer HY; Li Z; Kaneda Y; Ichikawa J
    Prog Neuropsychopharmacol Biol Psychiatry; 2003 Oct; 27(7):1159-72. PubMed ID: 14642974
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serotonergic modulation of dopamine neurotransmission: a mechanism for enhancing therapeutics in schizophrenia.
    Haleem DJ
    J Coll Physicians Surg Pak; 2006 Aug; 16(8):556-62. PubMed ID: 16899192
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Neuroleptics and serotonin].
    Hery F; Hamon M
    Encephale; 1993; 19(5):525-32. PubMed ID: 7905821
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Schizophrenia.
    Bladessarini RJ
    N Engl J Med; 1977 Nov; 297(18):988-95. PubMed ID: 20577
    [No Abstract]   [Full Text] [Related]  

  • 15. Serotonin-dopamine interactions: implications for the design of novel therapeutic agents for psychiatric disorders.
    Wood MD; Wren PB
    Prog Brain Res; 2008; 172():213-30. PubMed ID: 18772035
    [TBL] [Abstract][Full Text] [Related]  

  • 16. D2 and 5-HT2 receptor effects of antipsychotics: bridging basic and clinical findings using PET.
    Remington G; Kapur S
    J Clin Psychiatry; 1999; 60 Suppl 10():15-9. PubMed ID: 10340683
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Schizophrenia and dopamine (author's transl)].
    Toru M
    Tanpakushitsu Kakusan Koso; 1978; 23(4):303-16. PubMed ID: 26107
    [No Abstract]   [Full Text] [Related]  

  • 18. Pharmacotherapy of schizophrenia: a review.
    Sigmundson HK
    Can J Psychiatry; 1994 Nov; 39(9 Suppl 2):S70-5. PubMed ID: 7533053
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dopamine and schizophrenia--proof at last?
    Harrison PJ
    Lancet; 2000 Sep; 356(9234):958-9. PubMed ID: 11041394
    [No Abstract]   [Full Text] [Related]  

  • 20. Receptor pharmacology of neuroleptics: relation to clinical effects.
    Richelson E
    J Clin Psychiatry; 1999; 60 Suppl 10():5-14. PubMed ID: 10340682
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.